HRP20020242B1 - Production of a preparation comprising one or more antibiotics - Google Patents

Production of a preparation comprising one or more antibiotics

Info

Publication number
HRP20020242B1
HRP20020242B1 HR20020242A HRP20020242A HRP20020242B1 HR P20020242 B1 HRP20020242 B1 HR P20020242B1 HR 20020242 A HR20020242 A HR 20020242A HR P20020242 A HRP20020242 A HR P20020242A HR P20020242 B1 HRP20020242 B1 HR P20020242B1
Authority
HR
Croatia
Prior art keywords
sulfonates
cycloalkyl
sulfamates
alkylaryl
aryl
Prior art date
Application number
HR20020242A
Other languages
English (en)
Inventor
Vogt Sebastian
Schnabelrauch Matthias
K�hn Klaus-Dieter
Original Assignee
Heraeus Kulzer Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heraeus Kulzer Gmbh & Co. Kg filed Critical Heraeus Kulzer Gmbh & Co. Kg
Publication of HRP20020242A2 publication Critical patent/HRP20020242A2/hr
Publication of HRP20020242B1 publication Critical patent/HRP20020242B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20020242A 2001-03-22 2002-03-21 Production of a preparation comprising one or more antibiotics HRP20020242B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10114245A DE10114245A1 (de) 2001-03-22 2001-03-22 Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung

Publications (2)

Publication Number Publication Date
HRP20020242A2 HRP20020242A2 (en) 2002-12-31
HRP20020242B1 true HRP20020242B1 (en) 2005-02-28

Family

ID=7678692

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020242A HRP20020242B1 (en) 2001-03-22 2002-03-21 Production of a preparation comprising one or more antibiotics

Country Status (32)

Country Link
US (1) US20020183265A1 (xx)
EP (1) EP1243258B1 (xx)
JP (1) JP2002275098A (xx)
CN (1) CN1286467C (xx)
AT (1) ATE259636T1 (xx)
AU (1) AU772160B2 (xx)
BG (1) BG65505B1 (xx)
BR (1) BR0201099A (xx)
CA (1) CA2378503C (xx)
CZ (1) CZ2002868A3 (xx)
DE (2) DE10114245A1 (xx)
DK (1) DK1243258T3 (xx)
EE (1) EE200200155A (xx)
ES (1) ES2213718T3 (xx)
GE (1) GEP20053450B (xx)
HR (1) HRP20020242B1 (xx)
HU (1) HUP0201043A2 (xx)
IL (1) IL148705A (xx)
IS (1) IS2499B (xx)
MD (1) MD2353C2 (xx)
MX (1) MXPA02003006A (xx)
NO (1) NO20021389L (xx)
NZ (1) NZ517920A (xx)
PL (1) PL204985B1 (xx)
PT (1) PT1243258E (xx)
RU (1) RU2212880C1 (xx)
SA (1) SA02230036B1 (xx)
SK (1) SK3952002A3 (xx)
TR (1) TR200400363T4 (xx)
UA (1) UA71993C2 (xx)
YU (1) YU11702A (xx)
ZA (1) ZA200202255B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6389A (is) 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka, sem í eru örholrými, og einnig af þannig húðuðum skrokkum og notkun þeirra
IS6390A (is) 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka sem í eru örholrými, þannig húðuðum skrokkum og einnig af notkunþeirra
DE10227935B4 (de) * 2002-06-21 2007-10-04 Heraeus Kulzer Gmbh Verfahren zur Herstellung einer antibiotische Beschichtung von porösen Körpern sowie Verwendung
DE10318991A1 (de) * 2003-04-25 2004-11-18 Heraeus Kulzer Gmbh & Co. Kg Poröser Körper mit antibiotischer Beschichtung, Verfahren zur Herstellung sowie Verwendung
ZA200604869B (en) 2003-12-04 2007-11-28 Univ Utah Res Found Modified macromolecules and methods of making and using thereof
DE102004060666B3 (de) 2004-12-15 2006-03-30 Heraeus Kulzer Gmbh Antibiotikum/Antibiotika enthaltendes Knochenersatzmaterial mit retardierender Wirkstofffreisetzung
DE102005002703C5 (de) 2005-01-19 2013-07-04 Heraeus Kulzer Gmbh Antibiotische Beschichtung von Implantaten sowie Verfahren zur antibiotischen Beschichtung
US8685421B2 (en) 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
SI2007367T1 (sl) * 2007-02-16 2011-04-29 Alpharma Llc Krmni premiks z zdravilnim učinkom, ki vsebuje klortetraciklin hidroklorid
DE102007063613B4 (de) * 2007-04-24 2010-01-07 Heraeus Kulzer Gmbh Verwendung eines Spacer-Polymethylmethacrylat-Knochenzement
DE102007039871A1 (de) 2007-08-21 2009-02-26 Friedrich-Baur-Gmbh Weichgewebe-Implantat mit antibakterieller Wirkung
CN101225125B (zh) * 2008-01-18 2012-12-05 中国科学院烟台海岸带研究所 一种吸湿保湿剂及其制备方法
US8167836B2 (en) * 2009-12-08 2012-05-01 Taris Biomedical, Inc. Tissue expander configured for drug delivery
DE102010020940B4 (de) * 2010-05-19 2014-09-25 Heraeus Medical Gmbh Antibiotische Beschichtung
WO2013010045A1 (en) 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy
CN102391954B (zh) * 2011-10-26 2014-12-10 厦门大学 球形棕囊藻培养液的除菌方法
CN102552885A (zh) * 2011-12-16 2012-07-11 青岛海芬海洋生物科技有限公司 海洋生物痔疮及肛内上皮和直肠粘膜上皮细胞消炎修护液
JP6298468B2 (ja) 2012-10-16 2018-03-20 サーモディクス，インコーポレイテッド 創傷充填デバイスおよび方法
RU2540468C2 (ru) * 2012-11-06 2015-02-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Нижегородский государственный университет им. Н.И. Лобачевского"Российская Федерация Способ получения композиционных рассасывающихся материалов на основе хитозана и полилактида
EP2968880A1 (en) 2013-03-15 2016-01-20 TARIS Biomedical LLC Drug delivery devices with drug-permeable component and methods
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
WO2016172704A1 (en) 2015-04-23 2016-10-27 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
CN105999401B (zh) * 2016-07-22 2019-03-08 武汉理工大学 一种基于羟基磷灰石的牙科抑菌修复材料及其制备方法
CN107459654B (zh) * 2017-08-03 2020-05-26 天津大学 一种模拟抗菌肽共聚物及其制备方法
CN109674806B (zh) * 2019-01-14 2021-10-26 福州奥尼多生物科技有限公司 春雷霉素在制备抗菌药物中的用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091572A (en) * 1962-07-16 1963-05-28 Schering Corp Gentamycin and method of production
ES322771A1 (es) * 1966-02-08 1966-11-16 Folch Vazquez Conrado Procedimiento para la preparaciën de laurilsulfato de tetraciclina
ES315101A1 (es) * 1965-07-08 1966-01-01 Folch Vazquez Conrado Procedimiento de preparaciën de nuevos derivados de tetraciclina
FR6476M (xx) * 1967-06-06 1968-11-18
DE2320373B2 (de) * 1973-04-21 1978-04-06 Merck Patent Gmbh, 6100 Darmstadt Antibioticahaltiges Mittel und seine Verwendung als chirurgisches Kunststoffmaterial
FR2272680B1 (xx) * 1974-05-29 1978-07-21 Hosbon Sa Lab
AR216922A1 (es) * 1976-11-11 1980-02-15 Merck Patent Gmbh Procedimiento para la fabricacion de un medio quirurgico
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
DE3206725A1 (de) * 1981-05-13 1982-12-02 Merck Patent Gmbh, 6100 Darmstadt Schwer loesliche salze von aminoglykosidantibiotika
DE3248328A1 (de) * 1982-12-28 1984-06-28 Bayer Ag, 5090 Leverkusen Schwerloesliche salze von aminoglykosiden sowie diese enthaltende formulierungen mit verzoegerter wirkstoff-freigabe
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
FR2668367B1 (fr) * 1990-10-26 1994-05-13 Centre Nal Recherc Scientifique Medicament implantable a effet prolonge.
US5709875A (en) * 1990-10-26 1998-01-20 Centre National De La Rechierche Scientifique (C.N.R.S) Implantable biodegradable material and process for its production
DE4404018A1 (de) * 1994-02-09 1995-08-10 Merck Patent Gmbh Protrahiert freisetzende Darreichungsformen enthaltend Clindamycin-Palmitat
AU6439094A (en) * 1994-04-06 1995-10-30 Aktsionernoe Obschestvo Zakrytogo Tipa Firma "Assol" (Firma "Assol") Pharmaceutical agent for local application and a method of obtaining same
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
US5783217A (en) * 1995-11-07 1998-07-21 Etex Corporation Low temperature calcium phosphate apatite and a method of its manufacture
US5670142A (en) * 1996-07-08 1997-09-23 Donald Neudecker Treatment for itch of chicken pox
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
US5980928A (en) * 1997-07-29 1999-11-09 Terry; Paul B. Implant for preventing conjunctivitis in cattle
US6428579B1 (en) * 1998-07-01 2002-08-06 Brown University Research Foundation Implantable prosthetic devices coated with bioactive molecules
DE10114244A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung
DE10114364A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Verfahren zur Herstellung von antibiotischen Kompositen

Also Published As

Publication number Publication date
EE200200155A (et) 2002-12-16
IL148705A (en) 2006-12-10
DE10114245A1 (de) 2002-10-02
JP2002275098A (ja) 2002-09-25
DK1243258T3 (da) 2004-06-21
UA71993C2 (en) 2005-01-17
ZA200202255B (en) 2002-10-10
GEP20053450B (en) 2005-02-25
EP1243258A1 (de) 2002-09-25
RU2212880C1 (ru) 2003-09-27
PL204985B1 (pl) 2010-02-26
SA02230036B1 (ar) 2007-02-27
IL148705A0 (en) 2002-09-12
EP1243258B1 (de) 2004-02-18
IS2499B (is) 2009-03-15
BR0201099A (pt) 2002-11-05
AU2756202A (en) 2002-09-26
NO20021389D0 (no) 2002-03-20
NZ517920A (en) 2003-02-28
HRP20020242A2 (en) 2002-12-31
SK3952002A3 (en) 2002-10-08
CA2378503C (en) 2008-09-16
CA2378503A1 (en) 2002-09-22
ES2213718T3 (es) 2004-09-01
PT1243258E (pt) 2004-07-30
ATE259636T1 (de) 2004-03-15
HUP0201043A2 (hu) 2003-02-28
DE50200244D1 (de) 2004-03-25
PL352922A1 (en) 2002-09-23
BG106456A (en) 2002-10-31
US20020183265A1 (en) 2002-12-05
MD2353B2 (en) 2004-01-31
YU11702A (sh) 2004-12-31
AU772160B2 (en) 2004-04-08
TR200400363T4 (tr) 2004-03-22
MD20020073A (en) 2002-11-30
CZ2002868A3 (cs) 2002-11-13
MD2353C2 (ro) 2004-08-31
IS6271A (is) 2002-09-22
MXPA02003006A (es) 2003-08-20
NO20021389L (no) 2002-09-23
CN1286467C (zh) 2006-11-29
HU0201043D0 (xx) 2002-05-29
BG65505B1 (bg) 2008-10-31
CN1380064A (zh) 2002-11-20

Similar Documents

Publication Publication Date Title
HRP20020242B1 (en) Production of a preparation comprising one or more antibiotics
CA2378490A1 (en) Antibiotic/antibiotics (or: antibiotic(s)) preparation with retarding active ingredient release
JP2008518699A5 (xx)
CR6210A (es) Composiciones de celecoxib
BR0308289A (pt) Antibióticos do tipo florfenicol
NO20061468L (no) Anvendelse av tigecyklin, alene eller i kombinasjonmed rifampin for behandling av osteomyelitt og/eller septisk artritt
MD20020074A (en) Process for production of composite antibiotics
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
BRPI0519122A2 (pt) composiÇço oral, e, mÉtodo de reduzir o crescimento de placa bacteriana em uma cavidade oral de um indivÍduo
BRPI0519120A2 (pt) composiÇço para tratamento oral
BR0202759A (pt) Composição farmacêutica de liberação modificada contendo bupropiona como substância ativa
WO2001068675A3 (en) Treatment of rosacea
UA123396U (uk) Фармацевтична композиція у формі вагінальних таблеток для місцевого застосування у гінекології
DE60201022D1 (de) Antibiotische pharmazeutische formulierung mit lysergol zur verstärkung der wirksamkeit und behandlungsmethode
SE9902673D0 (sv) New composition
RU2003117895A (ru) Способ местного лечения неспецифических заболеваний эндобронхитов
ITBO930460A1 (it) Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.

Legal Events

Date Code Title Description
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
A1OB Publication of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20090320

Year of fee payment: 8

PBON Lapse due to non-payment of renewal fee

Effective date: 20100322